Full Paper
–
31P{1H} NMR (162 MHz, CDCl3): δ = 45.7 (s, PPh3), –144.4 (sept, PF6
H), 7.50 (m, 2 H, phen H), 7.46 (s, 1 H, phen H), 7.39–7.29 (m, 9 H,
) ppm. UV/Vis (CH3CN): λmax/nm (ε/mol–1 dm3 cm–1): 267 sh (20980), phenyl H), 7.23–7.10 (m, 18 H, phenyl H), 6.81 (s, 1 H, phen H), 2.46
271 sh (20270), 290 sh (15620), 308 sh (11870), 396 (1470).
(s, 3 H, -CH3), 2.20 (s, 3 H, -CH3), –11.09 (t, J = 18.8 Hz, 1 H, Ru–H)
ppm. 31P{1H} NMR (162 MHz, CDCl3): δ = 43.5 (s, PPh3), –144.2 (sept,
PF6–) ppm. UV/Vis (CH3CN): λmax/nm (ε/mol–1 dm3 cm–1): 225 sh
(61930), 248 sh (38270), 292 sh (33060), 330 sh (10270), 402 (2250).
[RuII(Ph2Phen)(CO)(H)(PPh3)2]PF6 (6): The synthetic method used
was similar to that of 1 except that the ligand Ph2Phen (83.5 mg,
[RuII(Me2Phen)(CO)(H)(PPh3)2]PF6 (2): The synthetic method is
similar to that of 1 except that the ligand Me2Phen (52.1 mg,
0.25 mmol) was used instead of Me2bpy. Yield 82.5 mg, 46.7 %.
Yield 106.4 mg, 50.2 %. Elemental analysis calcd. (%) for
C51H43F6N2OP3Ru (1007.89): C 60.78, H 4.30, N 2.78; found C 60.86,
H 4.41, N 2.75. IR (KBr): ν = ν(Ru–H) 2026; ν(C≡ O) 1937; ν(P–F) 841 0.25 mmol) was used instead of Me2bpy. Yield 103.4 mg, 43.5 %.
˜
1
cm–1. ESI-MS (positive): m/z = 863 [M+]. H NMR (300 MHz, CDCl3):
Elemental analysis calcd. (%) for C61H47F6N2OP3Ru (1132.03): C
δ = 8.44 (d, J = 8.3 Hz, 1 H, phen H), 8.02 (t, J = 8.5 Hz, 2 H, phen
64.72, H 4.18, N 2.47; found C 64.80, H 4.26, N 2.35. IR (KBr): ν =
˜
1
H), 7.86 (d, J = 8.7 Hz, 1 H, phen H), 7.52 (d, J = 8.3 Hz, 1 H, phen ν(C≡ O) 1942; ν(P–F) 838 cm–1. ESI-MS (positive): m/z = 987 [M+]. H
H), 7.31–7.24 (m, 9 H, phenyl H), 7.20–6.95 (m, 21 H, phenyl H), 6.87
(d, J = 8.3 Hz, 1 H, phen H), 2.41 (s, 3 H, CH3), 2.09 (s, 3 H, CH3),
–11.25 (t, J = 18.8 Hz, 1 H, Ru–H) ppm. 31P{1H} NMR (162 MHz,
CDCl3): δ = 43.6 (s, PPh3), –144.2 (sept, PF6–) ppm. UV/Vis (CH3CN):
NMR (300 MHz, CDCl3): δ = 9.22 (d, J = 5.3 Hz, 1 H, phen H), 8.13
(d, J = 5.3 Hz, 1 H, phen H), 7.90 (dt, J = 9.4 Hz, 2 H, phen H), 7.67–
7.54 (m, 8 H, phenyl H), 7.48 (dd, J = 7.6, 1.7 Hz, 2 H, phen H), 7.43–
7.36 (m, 2 H, phen H), 7.37–7.29 (m, 8 H, phenyl H), 7.27–7.15 (m,
22 H, phenyl H), –11.00 (t, J = 19.1 Hz, 1 H, Ru–H) ppm. 31P{1H} NMR
(162 MHz, CDCl3): δ = 46.1 (s, PPh3), –144.2 (sept, PF6–) ppm. UV/
Vis (CH3CN): λmax/nm (ε/mol–1 dm3 cm–1): 225 sh (55410), 289 sh
(28950), 322 sh (12290), 401 sh (3690).
λ
max/nm (ε/mol–1 dm3 cm–1): 226 sh (59060), 275 sh (25090), 318 sh
(7230), 395 (870).
[RuII(PhenCOOH)(CO)(H)(PPh3)2]PF6 (3): Compound 3 was pre-
pared by a procedure similar to that for 1, except PhenCOOH
(56.1 mg, 0.25 mmol) was used instead of Me2bpy. Yield 84.6 mg, [RuII(dpq)(CO)(H)(PPh3)2]PF6 (7): The synthetic method used was
45.8 %. Elemental analysis calcd. (%) for
(1023.85): C 58.66, H 3.84, N 2.74; found C 58.59, H 3.92, N 2.81. IR
(KBr): ν = ν(Ru–H) 2007; ν(C≡ O) 1945; ν(P–F) 841; ν(C=O) 1618 cm–1
C
50H39F6N2O3P3Ru
similar to that of 1 except that the ligand dpq (58.06 mg,
0.25 mmol) was used instead of Me2bpy. Yield 111.8 mg, 51.6 %.
Elemental analysis calcd. (%) for C51H39F6N4OP3Ru (1031.87): C
.
˜
ESI-MS (positive): m/z = 879 [M+]. 1H NMR (300 MHz, CDCl3): δ = 59.36, H 3.81, N 5.43; found C 59.22, H 3.95, N 5.38. IR (KBr): ν =
˜
9.45 (s, 1 H, -COOH), 8.35 (d, J = 7.6 Hz, 1 H, phen H), 8.14 (d, J =
8.8 Hz, 2 H, phen H), 7.73 (d, J = 8.6 Hz, 2 H, phen H), 7.58 (d, J =
ν(Ru–H) 2006; ν(C≡ O) 1941; ν(P–F) 840 cm–1. ESI-MS (positive): m/z =
887 [M+]. 1H NMR (300 MHz, CDCl3): δ = 9.38 (d, J = 8.1 Hz, 1 H,
8.1 Hz, 1 H, phen H), 7.24–7.31 (m, 12 H, phenyl H), 7.17–7.22 (m, 6 dpq H), 9.29 (t, J = 6.7 Hz, 2 H, dpq H), 9.14 (dd, J = 4.1, 2.0 Hz, 2
H, phenyl H), 7.05–7.14 (m, 12 H, phenyl H), 5.77 (s, 1 H, phen H),
–12.09 (t, J = 19.9 Hz, 1 H, Ru–H) ppm. 31P{1H} NMR (162 MHz,
CDCl3): δ = 44.5 (s, PPh3), –144.2 (sept, PF6–) ppm. UV/Vis (CH3CN):
H, dpq H), 8.13 (d, J = 5.5 Hz, 1 H, dpq H), 7.84 (dd, J = 8.3, 5.1 Hz,
1 H, dpq H), 7.26–7.12 (m, 30 H, phenyl H), 7.09 (dd, J = 8.2, 5.3 Hz,
1 H, dpq H), –11.15 (t, J = 19.2 Hz, 1 H, Ru–H) ppm. 31P{1H} NMR
(162 MHz, CDCl3): δ = 46.1 (s, PPh3), –144.2 (sept, PF6–) ppm. UV/
Vis (CH3CN): λmax/nm (ε/mol–1 dm3 cm–1): 2256 sh (47680), 298 sh
(23600), 322 sh (6550), 401 (2500).
[RuII(dpqc)(CO)(H)(PPh3)2]PF6 (8): The synthetic method used was
similar to that of 1 except that the ligand dpqc (71.6 mg,
0.25 mmol) was used instead of Me2bpy. Yield 114.7 mg, 50.3 %.
λ
max/nm (ε/mol–1·dm3·cm–1): 232 (38680), 270 sh (20220), 276 sh
(19800), 325 sh (6160), 425 sh (1370).
[RuII(PhenCN)(CO)(H)(PPh3)2]PF6 (4): PhenCN (51.5 mg,
0.25 mmol) was added to a suspension of [Ru(PPh3)3(CO)(H)2]
(200 mg, 0.21 mmol) in the presence of excess Et2NH·HCl (169 mg,
2.1 mmol) in EtOH (150 mL). The mixture was heated at reflux for
1 d under argon and then NH4PF6 (342 mg, 2.1 mmol) was added. Elemental analysis calcd. (%) for C55H45F6N4OP3Ru (1085.97): C
The mixture was heated at reflux for a further 1 h. The solvent
was removed under reduced pressure and the pale-yellow solid was
collected and washed with by water (3 × 4 mL) and then by ice-
cold methanol (3 × 4 mL). It was recrystallized by slow evaporation
of a CH2Cl2/MeOH (1:3, v/v) solution of the complex. Yield 80.6 mg,
44.6 %. Elemental analysis calcd. (%) for C50H38F6N3OP3Ru (1004.85):
60.83, H 4.18, N 5.16; found C 60.66, H 4.30, N 5.08. IR (KBr): ν =
˜
ν(Ru–H) 1971; ν(C≡ O) 1951; ν(P–F) 841 cm–1. ESI-MS (positive): m/z =
941 [M+]. 1H NMR (300 MHz, CDCl3): δ = 9.35 (d, J = 8.2 Hz, 1 H,
dpqc H), 9.24 (d, J = 7.9 Hz, 1 H, dpqc H), 9.17 (d, J = 5.2 Hz, 1 H,
dpqc H), 8.02 (d, J = 5.7 Hz, 1 H, dpqc H), 7.74 (dd, J = 8.3, 5.1 Hz,
1 H, dpqc H), 7.24 (m, 6 H, phenyl H), 7.22–7.09 (m, 24 H, phenyl
H), 7.01 (dd, J = 8.2, 5.3 Hz, 1 H, dpqc H), 2.14 (m, 4 H, -CH2), 1.56
(m, 4 H, -CH2), –11.14 (t, J = 19.4 Hz, 1 H, Ru–H) ppm. 31P{1H} NMR
(162 MHz, CDCl3): δ = 46.2 (s, PPh3), –144.2 (sept, PF6–) ppm. UV/
Vis (CH3CN): λmax/nm (ε/mol–1·dm3·cm–1): 224 sh (50380), 268 sh
(33460), 308 sh (15860), 342 sh (5653), 404 (1780).
C 59.76, H 3.81, N 4.18; found C 59.81, H 3.92, N 4.15. IR (KBr): ν =
˜
ν(C≡ O) 1951; ν(P–F) 839 cm–1. ESI-MS (negative): m/z = 860 [M+]. 1H
NMR (300 MHz, CDCl3): δ = 9.13 (d, J = 6 Hz, 1 H, phen H), 8.49 (dd,
J = 15.8, 7.9 Hz, 2 H, phen H), 8.19 (d, J = 1.9 Hz, 2 H, phen H), 7.63
(dd, J = 7.8, 5.4 Hz, 1 H, phen H), 7.31–7.36 (m, 8 H, phenyl H),
7.10–7.22 (m, 22 H, phenyl H), 5.33 (s, 1 H, phen H), –10.43 (t, J =
18.5 Hz, 1 H, Ru–H) ppm. 31P{1H} NMR (162 MHz, CDCl3): δ = 45.0
(s, PPh3), –144.4 (sept, PF6–) ppm. UV/Vis (CH3CN): λmax/nm
(ε/mol–1 dm3 cm–1): 276 (37350), 290 sh (26010), 324 sh (9080), 378
(3640), 465 (1180).
[RuII(dppz)(CO)(H)(PPh3)2]PF6 (9): The synthetic method used was
similar to that of 1 except that the ligand dppz (70.6 mg,
0.25 mmol) was used instead of Me2bpy. Yield 112 mg, 49.3 %. Ele-
mental analysis calcd. (%) for C55H41F6N4OP3Ru (1081.93): C 61.06,
H 3.82, N 5.18; found C 61.17, H 3.95, N 5.02. IR (KBr): ν = ν(Ru–H)
˜
[RuII(Me2Ph2phen)(CO)(H)(PPh3)2]PF6 (5): The synthetic method
2019; ν(C≡ O) 1939; ν(P–F) 839 cm–1. ESI-MS (positive): m/z = 937
used was similar to that of 1 except that the ligand Me2Ph2phen [M+]. H NMR (300 MHz, CDCl3): δ = 9.53 (d, J = 7.2 Hz, 1 H, dppz
1
(90.1 mg, 0.25 mmol) was used instead of Me2bpy. Yield 107.6 mg, H), 9.43 (d, J = 8.2 Hz, 1 H, dppz H), 9.32 (d, J = 5.1 Hz, 1 H, dppz
44.2 %. Elemental analysis calcd. (%) for C63H51F6N2OP3Ru (1160.09):
H), 8.45 (dd, J = 6.6, 3.4 Hz, 2 H, dppz H), 8.15 (d, J = 4.3 Hz, 1 H,
dppz H), 8.08 (dd, J = 6.6, 3.4 Hz, 2 H, dppz H), 7.88 (dd, J = 8.2,
C 65.23, H 4.43, N 2.41; found C 65.20, H 4.60, N 2.49. IR (KBr): ν =
˜
ν(Ru–H) 2032; ν(C≡ O) 1938; ν(P–F) 838 cm–1. ESI-MS (positive): m/z = 5.2 Hz, 1 H, dppz H), 7.28–7.10 (m, 30 H, phenyl H), –11.19 (d, J =
1015 [M+]. 1H NMR (300 MHz, CDCl3): δ = 7.98 (d, J = 9.3 Hz, 1 H, 19.1 Hz, 1 H, Ru–H) ppm. 31P{1H} NMR (162 MHz, CDCl3): δ = 46.0
phen H), 7.82 (d, J = 9.2 Hz, 1 H, phen H), 7.75–7.53 (m, 11 H, phenyl
(s, PPh3), –144.2 (sept, PF6–) ppm. UV/Vis (CH3CN): λmax/nm
Eur. J. Inorg. Chem. 0000, 0–0
6
© 0000 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim